Related Experiment Video
Updated: May 10, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Delayed onset malignant hyperthermia after sevoflurane
K Sanem Cakar Turhan1, Volkan Baytaş, Yeşim Batislam
1Department of Anaesthesiology and Reanimation, Ankara University Medical School, Ankara, Turkey.
Abstract:
Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity and rhabdomyolysis. In this case report, we present a case of delayed onset malignant hyperthermia-like reaction after the second exposure to sevoflurane.
Related Concept Videos
Increased Body Temperature
Inhalational Anesthetics: Overview
Types of Fever
Here are the different types of fever:
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Acute Respiratory Failure-III
Depolarizing Blockers: Pharmocokinetics
